The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Havens, A M ^a   Jung, Y H ^a   Sun, Y Xis ^a,d   Wang, J ^a   Shah, Raj B ^b   Bühring, Hans Joerg ^c   Pienta, K J ^b   Taichman, R S ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; SIALOMUCIN; STROMAL CELL DERIVED FACTOR 1;

ANTIGEN DETECTION; ARTICLE; BONE MARROW; CANCER CELL CULTURE; CANCER SCREENING; CELL ADHESION; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE FUNCTION; GENE IDENTIFICATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE HOMING; MALE; METASTASIS POTENTIAL; PROSTATE CANCER; PROTEIN EXPRESSION; REGULATORY MECHANISM; TISSUE MICROARRAY;

ANTIGENS, CD164; BONE MARROW NEOPLASMS; CELL ADHESION; CHEMOKINE CXCL12; CHEMOKINES, CXC; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; NEOPLASM METASTASIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 33748201733     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-195     Document Type: Article

References (46)

1. Pauli BU, Lee CL: Organ preference of metastasis: The role of organ-specifically modulated endothelial cells. Laboratory Investigation 1988, 58:379-387.
2. Jahroudi N, Greenberger JS: The role of endothelial cells in tumor invasion and metastasis. Journal of Neuro-Oncology 1995, 23:99-108.
3. Voura EB, Sandig M, Siu CH: Cell-cell interactions during transendothelial migration of tumor cells. Microsc Res Tech 1998, 43:265-275.
4. Nicolson GL, Custead SE: Tumor metastasis is not due to adaptation of cells to a new organ environment. Science 1982, 215:176-178.
5. Fidler IJ: The pathogenesis of cancer metastasis: the'seed and soil' hypothesis revisited. Nature Reviews Cancer 2003, 3(6):453-8.
6. Reddi AH, Roodman D, Freeman C, Mohla S: Mechanisms of tumor metastasis to the bone: challenges and opportunities. Journal of Bone & Mineral Research 2003, 18(2):190-4.
7. Aiuti A, Tavian M, Cipponi A, Ficara F, Zappone E, Hoxie J, Peault B, Bordignon C: Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors. European Journal of Immunology 1999, 29:1823-1831.
8. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
9. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk, Nagler A, Ben-Hur H, Many A, Shultz L, Lider O, Alon P, Zipori D, Lapidot T: Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
10. Ponomaryov T, Peled A, Peled I, Taichman RS, Habler L, Sandbank J, Arenzana-Seisdedos G, Nagler A, Lahav M, Szyper-Kravitz M, Zipori D, Lapidot T: Increased Production of SDF-1 Following Treatment with DNA Damaging Agents: Relevance for Human Stem Cell Homing and Repopulation of NOD/SCID Mice. J Clin Invest 2000, 106:1331-1339.
11. Sun YX, Wang J, C.E. S, D.E. L, A.M. C, K.J. P, Rubin MA, Taichman RS: The expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003, 89:462-473.
12. Sun YX, Schneider A, Jung Y, Wang J, Dai J, Wang J, Cook K, Osman NI, Koh-Paige AJ, Shim H, Pienta KJ, Keller ET, McCauley LK, Taichman RS: Skeletal Localization and Neutralization of the SDF-1 (CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo. Journal of Bone & Mineral Research 2005:318-329.
13. Wang JH, Wang J, Sun YX, Song W, Nor J, Wang CY, Taichman RS: Signaling Through SDF-1/CXCR4 in Prostate Cancer Cell Lines Leads to Altered Patterns of Cytokine Secretion & Angiogenesis. Cellular Signalling 2005, 17:1578-1592.
14. RS T, C C, ET K, KJ P, Taichman NS, LK. MC: Use of the Stromal Cell-derived Factor-1/CXCR4 Pathway in Prostate Cancer Metastasis to Bone. Cancer Res 2002, 62:1832-1837.
15. Kang YB, Siegel PM, Shu WP, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549.
16. Muller CA, Homey B, Sato H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagners SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
17. Robledo MM, Bartolome RA, Longo N, Rodriguez-Frade JM, Mellado M, Longo I, van MGN, Sanchez-Mateos P, Teixido J: Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 2001, 276:45098-45105.
18. Gerritsen ME, Peale FVJ, Wu T: Gene expression profiling in silico: relative expression of candidate angiogenesis associated genes in renal cell carcinomas. Ecperimental Nephrology 2002, 10:114-119.
19. Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, Fujii N, Imamura M: Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 2000, 6:3530-3535.
20. Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R, Beider K, Avniel S, Kasem S, Galun E, Peled A: Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB Journal 18(11):1240-2, 2004.
21. Vaday GG, Hua SB, Peehl DM, Pauling MH, Lin YH, Zhu L, Lawrence DM, Foda HD, Zucker S: CXCR4 and CXCL12 (SDF-1) in prostate cancer: Inhibitory effects of human single chain Fv antibodies. Clin Cancer Res 2004, 10:5630-5639.
22. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM: Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412:822-826.
23. Chan JYH, Lee-Prudhoe JE, Jorgensen B, Ihrke G, Doyonnas R, Zannettino ACW, Buckle VJ, Ward CJ, Simmons PJ, Watt SM: Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/endolyn. J Biol Chem 2001, 276:2139-2152.
24. Masuzawa Y, Miyauchi T, Hamanoue M, Ando S, Yoshida J, Takao S, Shimazu H, Adachi M, Muramatsu T: A Novel Core Protein As Well As Polymorphic Epithelial Mucin Carry Peanut Agglutinin Binding-Sites in Human Gastric-Carcinoma Cells - Sequence-Analysis and Examination of Gene-Expression. Journal of Biochemistry 1992, 112:609-615.
25. Ihrke G, Gray SR, Luzio JP: Endolyn is a mucin-like type I membrane protein targeted to lysosomes by its cytoplasmic tail. Biochemical Journal 2000, 345:287-296.
26. Doyonnas R, Chan JYH, Butler LH, Rappold I, Lee-Prudhoe JE, Zannettino ACW, Simmons PJ, Buhring HJ, Levesque JP, Watt SM: CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor. J Immunol 2000, 165:840-851.
27. Kurosawa N, Kanemitsu Y, Matsui T, Shimada K, Ishihama H, Muramatsu T: Genomic analysis of a murine cell-surface sialomucin, MGC-24/CD164. Eur J Biochem 1999, 265:466-472.
28. Watt SM, Buhring HJ, Rappold I, Chan JYH, Lee-Prudhoe J, Jones T, Zannettino ACW, Simmons PJ, Doyonnas R, Sheer D, Butler LH: DC164, a novel sialomucin on CD34(+) and erythroid subsets is located on human chromosome 6q21. Blood 1998, 92:849-866.
29. 2006 [http://biosunl.harvard.edu/complab/dchip/].
30. Rubin MA, Putzi M, Mucci N, Smith DC, Wojno K, Korenchuk S, Pienta KJ: Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. Clin Cancer Res 2000, 6:1038-1045.
31. Shah RB, Mehra R, Chinnaiyan AM, Shen R, Ghosh D, Zhou M, MacVicar GR, Varambally S, Harwood J, Bismar TA, Kim R, Rubin MA, Pienta KJ: Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases: Lessons from a Rapid Autopsy Program. Cancer Res 2004, 64:9209-9216.
32. Perrone EE, Theoharis C, Mucci NR, Hayasaka S, Taylor JM, Cooney KA, Rubin MA: Tissue microarray assessment of prostate cancer tumor proliferation in African-American and white men. Journal of the National Cancer Institute 2000, 92:937-939.
33. 2006 [http://www.pvdb.path.med.umich.edu/htma/profiler/index.jsp].
34. Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L: The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998, 91:4523-4530.
35. Xiong M, Jin L, Li W, Boerwinkle E: Computational methods for gene expression-based tumor classification. BioTechniques 1270, 29:1264-1268.
36. Watt SM, Butler LH, Tavian M, Buhring HJ, Rappold I, Simmons PJ, Zannettino ACW, Buck D, Fuchs A, Doyonnas R, Chan JYH, Levesque JP, Peault B, Roxanis I: Functionally defined CD164 epitopes are expressed only CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues. Blood 2000, 95:3113-3124.
37. Stein BS, Vangore S, Petersen RO: Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites. Urology 24(2):146-52, 1984.
38. Shah NT, Tuttle SE, Strobel SL, Gandhi L: Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material. Journal of Surgical Oncology 29(4):265-8, 1985.
39. Shah RB, Mehra R, Chinnaiyan AM, Shen RL, Ghosh D, Zhou M, MacVicar GR, Varambally S, Harwood J, Bismar TA, Kim R, Rubin MA, Plenta KJ: Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program. Cancer Research 2004, 64:9209-9216.
40. Krempien B: Pathogenesis of bone metastasis and tumor osteopathies. Radiologe 1995, 35:1-7.
41. Weiss L, Orr FW, Honn KV: Interactions of cancer cells with the microvasculature during metastasis. FASEB Journal 1988, 2:12-21.
42. Liu AY, Roudier MP, True LD: Heterogeneity in Primary and Metastatic Prostate Cancer as Defined by Cell Surface CD Profile. Am J Pathol 2004, 165:1543-1556.
43. E.T. K, J. Z, CR. C, PC. S, LK. MC, KJ P: Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer & Metastasis Reviews 2001, 20:333-349.
44. Glinsky VV, Glinsky GV, Rittenhouse-Olson K, Huflejt ME, Glinskii OV, Deutscher SL, Quinn TP: The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Research 61(12):4851-7, 2001.
45. Cooper CR, Bhatia JK, Muenchen HJ, McLean L, Hayasaka S, Taylor J, Poncza PJ, Pienta KJ: The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines. Clinical & Experimental Metastasis 2002, 19:25-33.
46. Lee YN, Kang JS, Krauss RS: Identification of a Role for the Sialomucin CD164 in Myogenic Differentiation by Signal Sequence Trapping in Yeast. Mol Cell Biol 2001, 21:7696.